| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 61.9% | 13/21 |
| Female | 38.1% | 8/21 |
| Indifferent | 0% | 0/21 |
| Unknown | 0% | 0/21 |
| General | ||
| Birth Length | 0% | 0/21 |
| Birth Weight | 0% | 0/21 |
| Birth Head circumference | 0% | 0/21 |
| 19% | 4/21 | |
| 4.8% | 1/21 | |
| 19% | 4/21 | |
| 66.7% | 14/21 | |
| 85.7% | 18/21 | |
| 66.7% | 14/21 | |
| 78.6% | 11/14 | |
| Neurology | ||
| 90.5% | 19/21 | |
| 33.3% | 7/21 | |
| 47.6% | 10/21 | |
| Facial abnormalities | ||
| 23.8% | 5/21 | |
| 28.6% | 6/21 | |
| 38.1% | 8/21 | |
| 42.9% | 9/21 | |
| Visual and hearing impairments | ||
| 19% | 4/21 | |
| 14.3% | 3/21 | |
| Heart | ||
| 14.3% | 3/21 | |
| Pulmonary | ||
| 9.5% | 2/21 | |
| Gastrointestinal | ||
| 52.4% | 11/21 | |
| Urogenital | ||
| 19% | 4/21 | |
| Skeleton | ||
| 47.6% | 10/21 | |
| Skin / Hair / Nails | ||
| 19% | 4/21 | |
| Endocrine / Immunological / Metabolic | ||
| 19% | 4/21 | |
| Metabolic | 0% | 0/21 |
| Immune | 0% | 0/21 |
| Neoplasia | ||
| 4.8% | 1/21 | |
| Inheritance | ||
| 68.4% | 13/19 | |
SUPT16H